Published in Infect Immun on January 19, 2010
Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria. Microbiol Mol Biol Rev (2012) 1.92
The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectors. Mol Microbiol (2010) 1.65
Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function. FEMS Microbiol Rev (2012) 1.26
Structure and biophysics of type III secretion in bacteria. Biochemistry (2013) 1.07
Quantitative assessment of cytosolic Salmonella in epithelial cells. PLoS One (2014) 0.95
Domains of the Shigella flexneri type III secretion system IpaB protein involved in secretion regulation. Infect Immun (2010) 0.93
Injection of Pseudomonas aeruginosa Exo toxins into host cells can be modulated by host factors at the level of translocon assembly and/or activity. PLoS One (2012) 0.92
Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation. Mol Microbiol (2013) 0.89
Three-dimensional electron microscopy reconstruction and cysteine-mediated crosslinking provide a model of the type III secretion system needle tip complex. Mol Microbiol (2014) 0.89
YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis. J Biol Chem (2010) 0.88
Structural characterization of a novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803. PLoS One (2012) 0.83
A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact. J Bacteriol (2013) 0.82
Identification and functional characterization of the novel Edwardsiella tarda effector EseJ. Infect Immun (2015) 0.82
Influence of oligomerization state on the structural properties of invasion plasmid antigen B from Shigella flexneri in the presence and absence of phospholipid membranes. Proteins (2014) 0.79
The Type III Secretion Translocation Pore Senses Host Cell Contact. PLoS Pathog (2016) 0.79
The Many Faces of IpaB. Front Cell Infect Microbiol (2016) 0.77
MxiA, MxiC and IpaD Regulate Substrate Selection and Secretion Mode in the T3SS of Shigella flexneri. PLoS One (2016) 0.77
Bacterial Control of Pores Induced by the Type III Secretion System: Mind the Gap. Front Immunol (2016) 0.76
Steps for Shigella Gatekeeper MxiC Function in Hierarchical Type III Secretion Regulation. J Biol Chem (2016) 0.75
Genetic Dissection of the Signaling Cascade that Controls Activation of the Shigella Type III Secretion System from the Needle Tip. Sci Rep (2016) 0.75
Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes. Front Cell Infect Microbiol (2016) 0.75
Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun (1982) 13.55
Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun (1986) 9.35
Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J Bacteriol (1993) 8.75
The type III secretion injectisome. Nat Rev Microbiol (2006) 7.62
Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin. Proc Natl Acad Sci U S A (1989) 7.00
Shigella flexneri induces apoptosis in infected macrophages. Nature (1992) 6.26
Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun (1987) 5.92
A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell (1986) 4.88
Experimental bacillary dysentery. An electron microscopic study of the response of the intestinal mucosa to bacterial invasion. Am J Pathol (1965) 4.42
MxiD, an outer membrane protein necessary for the secretion of the Shigella flexneri lpa invasins. Mol Microbiol (1993) 4.17
The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. EMBO J (1994) 4.02
IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J (1992) 3.84
The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes. J Cell Biol (1999) 3.75
Extracellular association and cytoplasmic partitioning of the IpaB and IpaC invasins of S. flexneri. Cell (1994) 3.53
IpaB mediates macrophage apoptosis induced by Shigella flexneri. Mol Microbiol (1994) 3.27
Type III secretion systems and bacterial flagella: insights into their function from structural similarities. Proc Natl Acad Sci U S A (2003) 3.11
The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science (2005) 2.90
Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem (1998) 2.75
Exerimental acute colitis in the Rhesus monkey following peroral infection with Shigella flexneri. An electron microscope study. Am J Pathol (1968) 2.53
Enhanced secretion through the Shigella flexneri Mxi-Spa translocon leads to assembly of extracellular proteins into macromolecular structures. Mol Microbiol (1995) 2.52
Nucleotide sequence of the invasion plasmid antigen B and C genes (ipaB and ipaC) of Shigella flexneri. Microb Pathog (1988) 2.43
IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri. Infect Immun (2006) 2.24
The type III secretion system tip complex and translocon. Mol Microbiol (2008) 2.23
Molecular model of a type III secretion system needle: Implications for host-cell sensing. Proc Natl Acad Sci U S A (2006) 2.16
Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation. Infect Immun (1997) 2.15
Helical structure of the needle of the type III secretion system of Shigella flexneri. J Biol Chem (2003) 2.15
Cytoskeletal rearrangements and the functional role of T-plastin during entry of Shigella flexneri into HeLa cells. J Cell Biol (1995) 2.06
Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J Clin Invest (1994) 1.95
The needle component of the type III secreton of Shigella regulates the activity of the secretion apparatus. J Biol Chem (2005) 1.92
Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. Mol Microbiol (2002) 1.90
Bacterial injectisomes: needle length does matter. Science (2005) 1.86
In vivo apoptosis in Shigella flexneri infections. Infect Immun (1996) 1.81
Bile salts stimulate recruitment of IpaB to the Shigella flexneri surface, where it colocalizes with IpaD at the tip of the type III secretion needle. Infect Immun (2007) 1.75
IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes. Infect Immun (2005) 1.73
Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD. J Biol Chem (2006) 1.72
Salmonella enterica serovar typhimurium pathogenicity island 1-encoded type III secretion system translocases mediate intimate attachment to nonphagocytic cells. Infect Immun (2009) 1.68
Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest (1995) 1.67
The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion. Mol Microbiol (2005) 1.66
A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Mol Microbiol (2005) 1.61
Plasmid-mediated contact haemolytic activity in Shigella species: correlation with penetration into HeLa cells. Ann Inst Pasteur Microbiol (1988) 1.60
Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol (2007) 1.60
What's the point of the type III secretion system needle? Proc Natl Acad Sci U S A (2008) 1.58
The type III secretion system needle tip complex mediates host cell sensing and translocon insertion. Mol Microbiol (2007) 1.58
Plasmid-associated adherence of Shigella flexneri in a HeLa cell model. Infect Immun (1989) 1.53
Shigella flexneri: genetics of entry and intercellular dissemination in epithelial cells. Curr Top Microbiol Immunol (1994) 1.46
Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri. Microbiology (2005) 1.46
Liposomes recruit IpaC to the Shigella flexneri type III secretion apparatus needle as a final step in secretion induction. Infect Immun (2009) 1.45
IpaB-IpgC interaction defines binding motif for type III secretion translocator. Proc Natl Acad Sci U S A (2009) 1.37
Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect Immun (1997) 1.33
Spa32 regulates a switch in substrate specificity of the type III secreton of Shigella flexneri from needle components to Ipa proteins. J Bacteriol (2002) 1.31
Phagocytosis of bacterial pathogens: implications in the host response. Semin Immunol (2001) 1.21
Identification of the cis-acting site involved in activation of promoters regulated by activity of the type III secretion apparatus in Shigella flexneri. J Bacteriol (2002) 1.16
Characterization of the interaction partners of secreted proteins and chaperones of Shigella flexneri. Mol Microbiol (2001) 1.15
MxiC is secreted by and controls the substrate specificity of the Shigella flexneri type III secretion apparatus. Mol Microbiol (2008) 1.13
Identification of the MxiH needle protein residues responsible for anchoring invasion plasmid antigen D to the type III secretion needle tip. J Biol Chem (2007) 1.04
Structure-function analysis of the Shigella virulence factor IpaB. J Bacteriol (2001) 1.00
Tripeptidyl peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis. Infect Immun (2000) 0.94
Correlation between Congo red binding as virulence marker in Shigella species and Sereny test. Roum Arch Microbiol Immunol (1992) 0.90
Intestinal M cells and their role in bacterial infection. Int J Med Microbiol (2003) 0.88
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med (2004) 3.61
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature (2009) 2.81
A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol (2008) 2.22
Molecular model of a type III secretion system needle: Implications for host-cell sensing. Proc Natl Acad Sci U S A (2006) 2.16
Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02
Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD. J Biol Chem (2006) 1.72
Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout. Nat Struct Mol Biol (2009) 1.70
The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectors. Mol Microbiol (2010) 1.65
Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc Natl Acad Sci U S A (2013) 1.63
What's the point of the type III secretion system needle? Proc Natl Acad Sci U S A (2008) 1.58
The type III secretion system needle tip complex mediates host cell sensing and translocon insertion. Mol Microbiol (2007) 1.58
Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Med Genet (2003) 1.43
Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP. PLoS Pathog (2012) 1.29
Timing is everything: the regulation of type III secretion. Cell Mol Life Sci (2009) 1.27
Architecture of the major component of the type III secretion system export apparatus. Nat Struct Mol Biol (2012) 1.24
Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton. J Bacteriol (2008) 1.24
Structure of the TatC core of the twin-arginine protein transport system. Nature (2012) 1.23
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci U S A (2013) 1.16
Structure of a type III secretion needle at 7-Å resolution provides insights into its assembly and signaling mechanisms. Proc Natl Acad Sci U S A (2012) 1.13
Crystal structure of Spa40, the specificity switch for the Shigella flexneri type III secretion system. Mol Microbiol (2008) 1.12
Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A (2011) 1.12
The structure of OMCI, a novel lipocalin inhibitor of the complement system. J Mol Biol (2007) 1.09
Expression, purification, crystallization and preliminary crystallographic analysis of MxiH, a subunit of the Shigella flexneri type III secretion system needle. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 1.08
Crystal structures of the CPAP/STIL complex reveal its role in centriole assembly and human microcephaly. Elife (2013) 1.07
Identification of minor inner-membrane components of the Shigella type III secretion system 'needle complex'. Microbiology (2007) 1.06
The oligomeric distribution of SecYEG is altered by SecA and translocation ligands. J Mol Biol (2005) 1.05
Quantitative volumetric breast imaging with 3D inverse scatter computed tomography. Conf Proc IEEE Eng Med Biol Soc (2012) 1.04
Fungicide-induced declines of freshwater biodiversity modify ecosystem functions and services. Ecol Lett (2012) 0.98
Expression, purification, crystallization and preliminary crystallographic analysis of BipD, a component of the Burkholderia pseudomallei type III secretion system. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.98
Pneumatosis Intestinalis Predictive Evaluation Study (PIPES): a multicenter epidemiologic study of the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg (2013) 0.98
Ongoing pain despite aggressive opioid pain management among persons with HIV. Clin J Pain (2010) 0.97
Structures of the Shigella flexneri type 3 secretion system protein MxiC reveal conformational variability amongst homologues. J Mol Biol (2008) 0.96
Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution. Structure (2013) 0.95
Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates. Infect Immun (2013) 0.95
Temperature-dependent FlgM/FliA complex formation regulates Campylobacter jejuni flagella length. Mol Microbiol (2010) 0.94
Domains of the Shigella flexneri type III secretion system IpaB protein involved in secretion regulation. Infect Immun (2010) 0.93
Electrical protein detection in cell lysates using high-density peptide-aptamer microarrays. J Biol (2008) 0.93
Biochemical analysis of the Plasmodium falciparum erythrocyte-binding antigen-175 (EBA175)-glycophorin-A interaction: implications for vaccine design. J Biol Chem (2013) 0.92
Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II. Dis Model Mech (2011) 0.92
Shigella flexneri Spa15 crystal structure verified in solution by double electron electron resonance. J Mol Biol (2010) 0.91
GFP plasmid-induced defects in Salmonella invasion depend on plasmid architecture, not protein expression. Microbiology (2009) 0.91
Differences in Salmonella enterica serovar Typhimurium strain invasiveness are associated with heterogeneity in SPI-1 gene expression. Microbiology (2011) 0.90
Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47. J Biol Chem (2014) 0.90
The natural antimicrobial carvacrol inhibits Campylobacter jejuni motility and infection of epithelial cells. PLoS One (2012) 0.90
Slow-light, band-edge waveguides for tunable time delays. Opt Express (2005) 0.90
High-resolution structures of bacterially expressed soluble human CD59. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.90
Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Clin Infect Dis (2011) 0.89
Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation. Mol Microbiol (2013) 0.89
Three-dimensional electron microscopy reconstruction and cysteine-mediated crosslinking provide a model of the type III secretion system needle tip complex. Mol Microbiol (2014) 0.89
Expression, purification, cocrystallization and preliminary crystallographic analysis of sucrose octasulfate/human complement regulator factor H SCRs 6-8. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.89
Structural and functional studies on the N-terminal domain of the Shigella type III secretion protein MxiG. J Biol Chem (2011) 0.88
Sub-lethal levels of carvacrol reduce Salmonella Typhimurium motility and invasion of porcine epithelial cells. Vet Microbiol (2011) 0.87
High-Q enhancement of attractive and repulsive optical forces between coupled whispering-gallery- mode resonators. Opt Express (2005) 0.85
SepL resembles an aberrant effector in binding to a class 1 type III secretion chaperone and carrying an N-terminal secretion signal. J Bacteriol (2010) 0.85
Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein. PLoS Pathog (2013) 0.85
Secretory cell hyperplasia and defects in Notch activity in a mouse model of leukocyte adhesion deficiency type II. Gastroenterology (2009) 0.84
Objective and subjective responses to a mechanical external nasal dilator in healthy children and children with nasal congestion. Allergy Asthma Proc (2015) 0.84
Structures of the rat complement regulator CrrY. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.84
A method to achieve homogeneous dispersion of large transmembrane complexes within the holes of carbon films for electron cryomicroscopy. J Struct Biol (2013) 0.84
LuxS-based quorum sensing does not affect the ability of Salmonella enterica serovar Typhimurium to express the SPI-1 type 3 secretion system, induce membrane ruffles, or invade epithelial cells. J Bacteriol (2009) 0.83
Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells. Infect Immun (2011) 0.82
Isolation of Salmonella mutants resistant to the inhibitory effect of Salicylidene acylhydrazides on flagella-mediated motility. PLoS One (2013) 0.82
Abnormal accumulation and recycling of glycoproteins visualized in Niemann-Pick type C cells using the chemical reporter strategy. Proc Natl Acad Sci U S A (2013) 0.82
With phases: how two wrongs can sometimes make a right. Acta Crystallogr D Biol Crystallogr (2010) 0.81
Benzotriazinone and benzopyrimidinone derivatives as potent positive allosteric AMPA receptor modulators. Bioorg Med Chem Lett (2011) 0.81
On-surface assembly of coiled-coil heterodimers. Langmuir (2012) 0.81
Novel poxvirus in big brown bats, northwestern United States. Emerg Infect Dis (2013) 0.80
Variables associated with decreasing pain among persons living with human immunodeficiency virus: a longitudinal follow-up study. Clin J Pain (2012) 0.80
A case of community-acquired Acinetobacter junii-johnsonii cellulitis. Biomedica (2012) 0.80
Role of the H domain of the histidine kinase-like protein NifL in signal transmission. J Biol Chem (2007) 0.79
Needle length control and the secretion substrate specificity switch are only loosely coupled in the type III secretion apparatus of Shigella. Microbiology (2012) 0.79
Putting the structure into complement. Immunobiology (2012) 0.79
ErpC, a member of the complement regulator-acquiring family of surface proteins from Borrelia burgdorferi, possesses an architecture previously unseen in this protein family. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.79
Improving IV iron and anemia management in the hemodialysis setting: a collaborative CQI approach. Nephrol Nurs J (2007) 0.78
Safety of drotrecogin alfa (activated) in surgical patients with severe sepsis. Surg Infect (Larchmt) (2004) 0.78
Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolin-associated protein-1 (MAP-1). J Biol Chem (2012) 0.77
Low-fractional oxygen concentration continuous positive airway pressure is effective in the prehospital setting. Prehosp Emerg Care (2011) 0.77
Coral reef disturbance and recovery dynamics differ across gradients of localized stressors in the Mariana Islands. PLoS One (2014) 0.77
Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA library. Blood (2002) 0.77
Tetartohedral twinning could happen to you too. Acta Crystallogr D Biol Crystallogr (2012) 0.77
Mislocalization of large ARF-GEFs as a potential mechanism for BFA resistance in COG-deficient cells. Exp Cell Res (2011) 0.76
Pyogranuloma caused by Mycobacterium asiaticum infection in a steer. J Vet Diagn Invest (2005) 0.75
Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs. Bioorg Med Chem Lett (2005) 0.75
Geiger-mode avalanche photodiode ladar receiver performance characteristics and detection statistics. Appl Opt (2009) 0.75
Nano-scale photonic crystal microcavity characterization with an all-fiber based 1.2 - 2.0 mum supercontinuum. Opt Express (2005) 0.75
Breeding in America: Neglected tropical diseases taking hold in U.S. Mod Healthc (2015) 0.75
A randomized trial comparing metallic and absorbable staples for closure of a Pfannenstiel incision for cesarean delivery. Am J Obstet Gynecol (2013) 0.75
Quantitative characterization of higher-order mode converters in weakly multimoded fibers. Opt Express (2003) 0.75
Re:imagine: a report on the UHC Annual Conference 2012. Am J Med Qual (2013) 0.75
Organizing for the 'second curve': combining health plans and provider systems. Healthc Financ Manage (2015) 0.75